Orthoproducts

Investment overview

Orthoproducts has two divisions, both leaders in their segments of the $16 billion global orthopaedic implant and equipment market. Orthoplastics is the established provider (45% market share) of the world’s highest quality, medical-grade ultra high molecular weight polyethylene for knee- and hip-joint replacements. Orthoponents (formerly LPE) is a specialised manufacturer of advanced hip stem replacements. A number of key customers are based in North America and the company continues to win and retain major customers internationally.